Endogenous Human SMN1 Promoter-driven Gene Replacement Improves the Efficacy and Safety of AAV9-mediated Gene Therapy for SMA in mice

被引：0
|
作者：
Xie, J. [1 ]
Xie, Q. [1 ]
Ma, H. [1 ]
Chen, X. [1 ]
Zhu, Y. [2 ]
Ma, Y. [2 ]
Jalinous, L. [2 ]
Su, Q. [1 ]
Tai, P. [1 ]
Gao, G. [1 ]
机构：
[1] Umass Chan Med Sch, Gene Therapy Ctr, Worcester, MA USA
[2] CANbridge Pharmaceut, Cambridge, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LSVP.05
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome
    Zhao, Piming
    Tassew, Gizachew B.
    Lee, Joanna Y.
    Oskouian, Babak
    Munoz, Denise P.
    Hodgin, Jeffrey B.
    Watson, Gordon L.
    Tang, Felicia
    Wang, Jen-Yeu
    Luo, Jinghui
    Yang, Yingbao
    King, Sarah
    Krauss, Ronald M.
    Keller, Nancy
    Saba, Julie D.
    JCI INSIGHT, 2021, 6 (08)
  • [22] AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice
    Zhang, Ying
    Ma, Hong
    Zhang, Jinchun
    Liu, Shilian
    Liu, Yanxin
    Zheng, Dexian
    LIFE SCIENCES, 2008, 82 (23-24) : 1154 - 1161
  • [23] Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice
    Bauer, Ralf
    Enns, Helene
    Jungmann, Andreas
    Leuchs, Barbara
    Volz, Christian
    Schinkel, Stefanie
    Koch, Walter J.
    Raake, Philip W.
    Most, Patrick
    Katus, Hugo A.
    Mueller, Oliver J.
    NEUROMUSCULAR DISORDERS, 2019, 29 (03) : 231 - 241
  • [24] AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C
    Georgiou, Elena
    Kagiava, Alexia
    Sargiannidou, Irene
    Schiza, Natasa
    Stavrou, Marina
    Richter, Jan
    Tryfonos, Christina
    Zetterberg, Henrik
    Heslegrave, Amanda
    Christodoulou, Christina
    Kleopa, Kleopas A.
    MOLECULAR THERAPY, 2023, 31 (11) : 3290 - 3307
  • [25] Arterial spin labeling CMR quantifies increased perfusion in hearts of mice treated with cardioprotective, AAV9-mediated EcSOD gene therapy prior to myocardial infarction
    Brent A French
    Konkal-Matt R Prasad
    Moriel H Vandsburger
    Ronald J Beyers
    Yaqin Xu
    Robert L Janiczek
    Craig H Meyer
    Frederick H Epstein
    Journal of Cardiovascular Magnetic Resonance, 12 (Suppl 1)
  • [26] Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness
    Isgrig, Kevin
    Cartagena-Rivera, Alexander X.
    Wang, Hong Jun
    Grati, Mhamed
    Fernandez, Katharine A.
    Friedman, Thomas B.
    Belyantseva, Inna A.
    Chien, Wade
    MOLECULAR THERAPY, 2023, 31 (09) : 2783 - 2795
  • [27] AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice
    Choi, Vivian W.
    Bigelow, Chad E.
    Mcgee, Terri L.
    Gujar, Akshata N.
    Li, Hui
    Hanks, Shawn M.
    Vrouvlianis, Joanna
    Maker, Michael
    Leehy, Barrett
    Zhang, Yiqin
    Aranda, Jorge
    Bounoutas, George
    Demirs, John T.
    Yang, Junzheng
    Ornberg, Richard
    Wang, Yu
    Martin, Wendy
    Stout, Kelly R.
    Argentieri, Gregory
    Grosenstein, Paul
    Diaz, Danielle
    Turner, Oliver
    Jaffee, Bruce D.
    Police, Seshidhar R.
    Dryja, Thaddeus P.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2 : 15022
  • [28] AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency
    Zhu, Lei
    Tan, Brandon
    Dwight, Selina S.
    Beahm, Brendan
    Wilsey, Matt
    Crawford, Brett E.
    Schweighardt, Becky
    Cook, Jennifer W.
    Wechsler, Thomas
    Mueller, William F.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 27 : 259 - 271
  • [29] AAV-mediated Lpcat1 gene replacement therapy rescues retinal degeneration in rd11 mice
    Dai, Xufeng
    Han, Juanjuan
    Jin, Zi-Bing
    Qi, Yan
    Li, Jie
    Deng, Wen-Tao
    Chang, Bo
    Hauswirth, William
    Pang, Ji-Jing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [30] Treatment of SMA type 1 infants using a single-dose AAV9-mediated gene therapy via intrathecal injection of GC101: An open-label, single-arm study
    Ma Xiuwei
    Zhuang Lu
    Ma Wenhao
    Li Jun
    Wang Xiaodong
    Li Zhongqiu
    Jiang Xinyang
    Wang Yongxia
    Du Ying
    Zhang Yingqian
    He Fang
    Zhu Zhiming
    Du Shaopeng
    Xu Juan
    Gu Ruijie
    Zhang Yanping
    Zhang Shan
    Li Ting
    Yang Xiao
    Zhang Sheng
    Zhu Lina
    Li Qiuping
    Dong Xiaoyan
    Wu Xiaobing
    Feng Zhichun
    中华医学杂志英文版, 2024, 137 (16)
12345